<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="Original Article" dtd-version="1.0" xml:lang="ko" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">kjh</journal-id>
<journal-title-group>
<journal-title>The Korean Journal of Hematology</journal-title>
<abbrev-journal-title>Korean J Hematol</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1738-7949</issn>
<issn pub-type="epub">2092-9129</issn>
<publisher>
<publisher-name>Korean Society of Hematology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.5045/kjh.2007.42.1.43</article-id>
<article-id pub-id-type="publisher-id">kjh-42-43</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Myelodysplastic Syndrome Associated with an Isolated del(5q) Chromosomal Abnormality Showing Poor Prognosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Chung</surname><given-names>Hee-Jung</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-kjh-42-43"/></contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Park</surname><given-names>Chan-Jeoung</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-kjh-42-43"/>
<xref ref-type="corresp" rid="c1-kjh-42-43"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Chi</surname><given-names>Hyun-Sook</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-kjh-42-43"/></contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Jang</surname><given-names>Seongsoo</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-kjh-42-43"/></contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Seo</surname><given-names>Eul Ju</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff1-kjh-42-43"/></contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Je-Hwan</given-names></name><degrees>M.D.</degrees>
<xref ref-type="aff" rid="aff01-kjh-42-43"><sup>1</sup></xref>
</contrib>
<aff id="aff1-kjh-42-43" xml:lang="en">Departments of Laboratory Medicine, Seoul, <country>Korea</country></aff>
<aff id="aff01-kjh-42-43" xml:lang="en"><label>1</label>Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, <country>Korea</country></aff>
</contrib-group>
<author-notes>
<corresp id="c1-kjh-42-43">Correspondence to&#xFF1A;Chan-Jeoung Park, M.D. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine 388-1, Pungnap 2-dong, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-4508, Fax: +82-02-478-0884 E-mail: <email>cjpark@amc.seoul.kr</email></corresp></author-notes>
<pub-date pub-type="ppub"><month>03</month><year>2007</year></pub-date>
<pub-date pub-type="epub"><day>19</day><month>03</month><year>2007</year></pub-date>
<volume>42</volume><issue>1</issue><fpage>43</fpage>
<lpage>47</lpage>
<history>
<date date-type="received"><day>10</day><month>10</month><year>2007</year></date>
<date date-type="rev-recd"><day>03</day><month>12</month><year>2007</year></date>
<date date-type="accepted"><day>21</day><month>12</month><year>2007</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2007 Korean Society of Hematology</copyright-statement>
<copyright-year>2007</copyright-year>
<license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<p>Typical myelodysplastic syndrome (MDS) associated with isolated del(5q) consists of an interstitial deletion of the band between q13 and q33 on chromosome 5. Generally, patients with isolated deletion 5q have better outcomes than those who have the deletion 5q with additional karyotypic abnormalities. Here we report a 47 year-old female with an isolated del(5q) chromosomal abnormality with an atypical breakpoint of 5q11q35 and rapid progression to acute leukemia, which had an exceptionally poor outcome. The peripheral blood revealed pancytopenia and occasional giant platelets, and the patient had hypercellular bone marrow with 4.8% blasts, as well as dysmegakaryopoiesis and dyserythropoiesis. Cytogenetically, the patient was del(5q)(q11.2q35)[18]/46,XX[2], showing that her deleted region was larger than that found for typical del 5q syndrome. Three months later, the patient presented with acute myelomonocytic leukemia with multilineage dysplasia. The cytogenetic findings were identical. Two months after allogeneic bone marrow transplantation, the patient died from severe graft-versus host disease.</p>
</abstract>
<kwd-group xml:lang="en">
<kwd>Myelodysplastic syndromes</kwd>
<kwd>Isolated deletion(5q)</kwd>
</kwd-group>
</article-meta>
</front>
<back><ref-list xml:lang="en"><title>REFERENCES</title><ref id="b1-kjh-42-43"><element-citation publication-type="journal"><label>1)</label><person-group person-group-type="author"><name><surname>Nimer</surname> <given-names>SD</given-names></name></person-group> <article-title>Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q</article-title> <source>J Clin Oncol</source> <year>2006</year><volume>24</volume> <fpage>2576</fpage><lpage>82</lpage></element-citation></ref>
<ref id="b2-kjh-42-43"><element-citation publication-type="journal"><label>2)</label><person-group person-group-type="author"><name><surname>Boultwood</surname> <given-names>J</given-names></name> <name><surname>Lewis</surname> <given-names>S</given-names></name> <name><surname>Wainscoat</surname> <given-names>JS</given-names></name></person-group> <article-title>The 5q-syndrome</article-title> <source>Blood</source> <year>1994</year><volume>84</volume> <fpage>3253</fpage><lpage>60</lpage></element-citation></ref>
<ref id="b3-kjh-42-43"><element-citation publication-type="journal"><label>3)</label><person-group person-group-type="author"><name><surname>Mathew</surname> <given-names>P</given-names></name> <name><surname>Tefferi</surname> <given-names>A</given-names></name> <name><surname>Dewald</surname> <given-names>GW</given-names></name> <etal/></person-group> <article-title>The 5q-syndrome: a single-institution study of 43 consecutive patients</article-title> <source>Blood</source> <year>1993</year><volume>81</volume> <fpage>1040</fpage><lpage>5</lpage></element-citation></ref>
<ref id="b4-kjh-42-43"><element-citation publication-type="journal"><label>4)</label><person-group person-group-type="author"><name><surname>Pedersen</surname> <given-names>B</given-names></name> <name><surname>Jensen</surname> <given-names>IM</given-names></name></person-group> <article-title>Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients</article-title> <source>Leukemia</source> <year>1991</year><volume>5</volume> <fpage>566</fpage><lpage>73</lpage></element-citation></ref>
<ref id="b5-kjh-42-43"><element-citation publication-type="book"><label>5)</label><person-group person-group-type="author"><name><surname>Jaffe</surname> <given-names>ES</given-names></name> <name><surname>Harris</surname> <given-names>NL</given-names></name> <name><surname>Stein</surname> <given-names>H</given-names></name> <name><surname>Vardiman</surname> <given-names>JW</given-names></name></person-group> <source>Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality</source> <edition>1st ed.</edition> <publisher-loc>Lyon</publisher-loc> <publisher-name>IARC Press</publisher-name> <year>2001</year> <fpage>73</fpage></element-citation></ref>
<ref id="b6-kjh-42-43"><element-citation publication-type="journal"><label>6)</label><person-group person-group-type="author"><name><surname>Giagounidis</surname> <given-names>AA</given-names></name> <name><surname>Germing</surname> <given-names>U</given-names></name> <name><surname>Aul</surname> <given-names>C</given-names></name></person-group> <article-title>Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies</article-title> <source>Clin Cancer Res</source> <year>2006</year><volume>12</volume> <fpage>5</fpage><lpage>10</lpage></element-citation></ref>
<ref id="b7-kjh-42-43"><element-citation publication-type="journal"><label>7)</label><person-group person-group-type="author"><name><surname>Boultwood</surname> <given-names>J</given-names></name> <name><surname>Fidler</surname> <given-names>C</given-names></name> <name><surname>Strickson</surname> <given-names>AJ</given-names></name> <etal/></person-group> <article-title>Transcription mapping of the 5q-syndrome critical region: Cloning of two novel genes and sequencing, expression, and mapping of a further six novel cdnas</article-title> <source>Genomics</source> <year>2000</year><volume>66</volume> <fpage>26</fpage><lpage>34</lpage></element-citation></ref>
<ref id="b8-kjh-42-43"><element-citation publication-type="journal"><label>8)</label><person-group person-group-type="author"><name><surname>Horrigan</surname> <given-names>SK</given-names></name> <name><surname>Arbieva</surname> <given-names>ZH</given-names></name> <name><surname>Xie</surname> <given-names>HY</given-names></name> <etal/></person-group> <article-title>Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31</article-title> <source>Blood</source> <year>2000</year><volume>95</volume> <fpage>2372</fpage><lpage>7</lpage></element-citation></ref>
<ref id="b9-kjh-42-43"><element-citation publication-type="journal"><label>9)</label><person-group person-group-type="author"><name><surname>Pedersen</surname> <given-names>B</given-names></name></person-group> <article-title>5q(-)survival: importance of gender and deleted 5q bands and survival analysis based on 324 published cases</article-title> <source>Leuk Lymphoma</source> <year>1998</year><volume>31</volume> <fpage>325</fpage><lpage>34</lpage></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-kjh-42-43" position="float">
<label>Fig. 1</label>
<caption xml:lang="en"><p>The findings at the diagnosis of myelodysplastic syndrome associated with isolated del(5q). (A) Occasional microme-gakaryocytes with hypolobulated nucleus in the bone marrow aspirates (Wright stain, &#x00D7;1,000). (B) Numerous mega-karyocytes of various sizes. Frequent hypolobulated micromegakaryocytes in the hypercellular bone marrow biopsy specimen (H&#x0026;E stain, &#x00D7;1,000).</p></caption>
<graphic xlink:href="kjh-42-43f1.tif"/>
</fig>
<fig id="f2-kjh-42-43" position="float">
<label>Fig. 2</label>
<caption xml:lang="en"><p>The findings of bone marrow aspiration at the diagnosis of acute myelomonocytic leukemia with multilineage dysplasia (AML M4 according to the FAB classification). (A) Blasts with prominent nucleoli and relatively abundant cytoplasm with small vacuoles (Wright stain, &#x00D7;1,000). (B) Erythroid dysplasia, including multinucleation, nuclear fragmentation, and basophilic stippling in the bone marrow aspirates (Wright stain, &#x00D7;1,000).</p></caption>
<graphic xlink:href="kjh-42-43f2.tif"/>
</fig>
<fig id="f3-kjh-42-43" position="float">
<label>Fig. 3</label>
<caption xml:lang="en"><p>(A) Karyotype analysis of the patient. del(5q)(q11.2q35) was observed in 18 of 20 me-taphases, indicating that the deleted region was larger than that in typical 5q deletion. (B) Ideogram of chromosome 5: break point of the patient (dotted line) and ordinary break point of MDS associated with isolated del(5q) (solid line).</p></caption>
<graphic xlink:href="kjh-42-43f3.tif"/>
</fig>
<table-wrap id="t1-kjh-42-43" position="float">
<label>Table 1.</label>
<caption xml:lang="en"><p>Clinical and pathologic characteristics of MDS associated with isolated del(5q) and the comparison with this patient</p></caption>
<table frame="hsides" rules="all">
<thead>
<tr>
<th valign="middle" align="left">solated del(5q)</th>
<th valign="middle" align="left">This patient</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">&#x2022;Clinical presentation</td>
<td valign="middle" align="left">&#x2022;Clinical presentation</td>
</tr>
<tr>
<td valign="middle" align="left">Older age (median 68 yea</td>
<td valign="middle" align="left">rs) Old age (47 year-old)</td>
</tr>
<tr>
<td valign="middle" align="left">Female predominance (7&#xFF1A;3 female to male)</td>
<td valign="middle" align="left">Female</td>
</tr>
<tr>
<td valign="middle" align="left">Refractory anemia</td>
<td valign="middle" align="left">Pancytopenia</td>
</tr>
<tr>
<td valign="middle" align="left">Low risk of leukemic progression</td>
<td valign="middle" align="left"><bold>Leukemic progression</bold></td>
</tr>
<tr>
<td valign="middle" align="left">Good prognosis</td>
<td valign="middle" align="left"><bold>Poor prognosis</bold></td>
</tr>
<tr>
<td valign="middle" align="left">&#x2022;Hematologic</td>
<td valign="middle" align="left">&#x2022;Hematologic</td>
</tr>
<tr>
<td valign="middle" align="left">presentation</td>
<td valign="middle" align="left">presentation</td>
</tr>
<tr>
<td valign="middle" align="left">Macrocytic anemia</td>
<td valign="middle" align="left">Normocytic anemia</td>
</tr>
<tr>
<td valign="middle" align="left">Modest leukopenia</td>
<td valign="middle" align="left">Modest leukopenia</td>
</tr>
<tr>
<td valign="middle" align="left">Normal/High platelet count</td>
<td valign="middle" align="left">s <bold>Low platelet count</bold></td>
</tr>
<tr>
<td valign="middle" align="left">del(5q)(q13q33)</td>
<td valign="middle" align="left"><bold>del(5q)(q11.2q35)</bold></td></tr>
<tr>
<td valign="middle" align="left">BM erythroid hypoplasia</td>
<td valign="middle" align="left"><bold>No BM erythroid hypoplasia</bold></td>
</tr>
<tr>
<td valign="middle" align="left">Hypolobulated</td>
<td valign="middle" align="left">Markedly hypolobulated</td>
</tr>
<tr>
<td valign="middle" align="left">megakaryocytes in BM</td>
<td valign="middle" align="left">megakaryocytes in BM</td>
</tr>
<tr>
<td valign="middle" align="left">&#xFF1C;5% BM blast count</td>
<td valign="middle" align="left">4.8% of BM blast count</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</back>
</article>